Uploaded June 2020 | Updated September 2026, 4 minutes ago
The Rockefeller University
Virtual Discussions with Genuine Experts Webinar Series
June 18, 2020
Speakers:
Richard P. Lifton, M.D., Ph.D., President and Carson Family Professor
Laboratory of Human Genetics and Genomics, The Rockefeller University
Paul Bieniasz, Ph.D., Professor
Laboratory of Retrovirology, The Rockefeller University
Investigator, Howard Hughes Medical Institute
Rockefeller University experts in infectious disease, immunology, biochemistry, structural biology, and genetics have projects underway that are aimed at understanding, preventing, and treating the SARS-CoV-2 virus, which is responsible for the current global COVID-19 pandemic. Virologist Paul Bieniasz and his lab members have developed techniques to measure the levels and potencies of antibodies that neutralize SARS-CoV-2. Using these approaches, their group has collaborated with investigators at Rockefeller, the New York Blood Center, and other institutions to help develop effective convalescent plasma and monoclonal antibody therapy for COVID-19 patients. For more information, visit: https://covid-19-research.rockefeller.edu.
The Rockefeller University
Virtual Discussions with Genuine Experts Webinar Series
June 18, 2020
Speakers:
Richard P. Lifton, M.D., Ph.D., President and Carson Family Professor
Laboratory of Human Genetics and Genomics, The Rockefeller University
Paul Bieniasz, Ph.D., Professor
Laboratory of Retrovirology, The Rockefeller University
Investigator, Howard Hughes Medical Institute
Rockefeller University experts in infectious disease, immunology, biochemistry, structural biology, and genetics have projects underway that are aimed at understanding, preventing, and treating the SARS-CoV-2 virus, which is responsible for the current global COVID-19 pandemic. Virologist Paul Bieniasz and his lab members have developed techniques to measure the levels and potencies of antibodies that neutralize SARS-CoV-2. Using these approaches, their group has collaborated with investigators at Rockefeller, the New York Blood Center, and other institutions to help develop effective convalescent plasma and monoclonal antibody therapy for COVID-19 patients. For more information, visit: https://covid-19-research.rockefeller.edu.
